Sodium oxybate: not authorised for fibromyalgia.
D000759:Adjuvants, Anesthesia / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D005062:European Union; D005356:Fibromyalgia / Q000188:drug therapy*; D006801:Humans; D012978:Sodium Oxybate / Q000009:adverse effects / Q000627:therapeutic use*
D000759:Adjuvants, Anesthesia; D012978:Sodium Oxybate